Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients

被引:71
|
作者
Van Everbroeck, B
Dobbeleir, I
De Waele, M
De Deyn, P
Martin, JJ
Cras, P
机构
[1] Univ Instelling Antwerp, Neurobiol Lab, Born Bunge Fdn, B-2610 Wilrijk, Belgium
[2] Univ Instelling Antwerp, Lab Neurochem & Behav, Born Bunge Fdn, B-2610 Wilrijk, Belgium
[3] Univ Instelling Antwerp, Neuropathol Lab, Born Bunge Fdn, B-2610 Wilrijk, Belgium
关键词
Alzheimer's disease; Creutzfeldt-Jacob disease; vascular dementia; dementia with Lewy bodies; clinical criteria; biochemical test;
D O I
10.1007/s00415-004-0311-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Our objective was to describe the clinical signs of 'possible' Creutzfeldt-Jakob disease (CJD) and to investigate whether current diagnostic criteria can accurately differentiate between different forms of dementia. We studied clinical data of 'definite' CJD, Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and vascular dementia (VD) patients. Two subgroups were used: the first consisted of patients with clinical signs compatible with 'possible' CJD but in whom another final diagnosis was made and a second group with a typical evolution of the respective dementia. More focal neurological deficits were observed in AD, DLB or VD patients initially classified as 'possible' CJD than in typical patients. A typical electroencephalogram showing periodic sharp wave complexes was observed in 26 (50%) CJD and 6% of other dementia patients. The 14-33 protein was detected in all CJD and 8% of other dementia patients. In patients with rapidly progressive dementia and focal neurological signs, CJD should be considered. When faced with the triad: dementia, myoclonus, and initial memory problems AD should be considered if the disease duration is longer than 1 year. The diagnosis of DLB is suggested, if Parkinsonism or fluctuations are present, whereas a focal onset and compatible brain imaging can indicate VD. Findings suggestive of CJD on EEG, brain imaging, and CSF do not exclude other dementias but make them very unlikely. These observations cannot only assist in the differential diagnosis of CJD but also with the identification of AD, DLB or VD patients with atypical clinical history.
引用
收藏
页码:298 / 304
页数:7
相关论文
共 50 条
  • [21] Coexistence of Creutzfeldt-Jakob disease, Lewy body disease, and Alzheimer's disease pathology: An autopsy case showing typical clinical features of Creutzfeldt-Jakob disease
    Haraguchi, Takashi
    Terada, Seishi
    Ishizu, Hideki
    Sakai, Kenichi
    Tanabe, Yasuyuki
    Nagai, Taiji
    Takata, Hiroshi
    Nobukuni, Keigo
    Ihara, Yuetsu
    Kitamoto, Tetsuyuki
    Kuroda, Shigetoshi
    NEUROPATHOLOGY, 2009, 29 (04) : 454 - 459
  • [22] Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease
    Zanusso, Gianluigi
    Fiorini, Michele
    Ferrari, Sergio
    Gajofatto, Alberto
    Cagnin, Annachiara
    Galassi, Andrea
    Richelli, Silvia
    Monaco, Salvatore
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (09): : 6281 - 6292
  • [23] Vascular dementia clinically resembling Creutzfeldt-Jakob disease
    Seno, H
    Ishino, H
    Inagaki, T
    Iijima, M
    Kikumoto, O
    Yoshinaga, J
    Matsuura, H
    Tachiyama, Y
    NEUROPATHOLOGY, 1997, 17 (02) : 117 - 120
  • [24] Treatable Neurological Disorders Misdiagnosed as Creutzfeldt-Jakob Disease
    Chitravas, Numthip
    Jung, Richard S.
    Kofskey, Diane M.
    Blevins, Janis E.
    Gambetti, Pierluigi
    Leigh, R. John
    Cohen, Mark L.
    ANNALS OF NEUROLOGY, 2011, 70 (03) : 437 - 444
  • [25] Spatial pattern of prion protein deposits in patients with sporadic Creutzfeldt-Jakob disease
    Armstrong, RA
    Cairns, NJ
    Lantos, PL
    NEUROPATHOLOGY, 2001, 21 (01) : 19 - 24
  • [26] Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob disease
    Blanquet-Grossard, F
    Sazdovitch, V
    Jean, A
    Deslys, JP
    Dormont, D
    Hauw, JJ
    Marion, D
    Brown, P
    Cesbron, JY
    JOURNAL OF DENTAL RESEARCH, 2000, 79 (02) : 700 - 700
  • [27] ERK2 is Increased in Cerebrospinal Fluid of Creutzfeldt-Jakob Disease Patients
    Steinacker, Petra
    Klafki, Hans
    Lehnert, Stefan
    Jesse, Sarah
    v Arnim, Christine A. F.
    Tumani, Hayrettin
    Pabst, Alice
    Kretzschmar, Hans A.
    Wiltfang, Jens
    Otto, Markus
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (01) : 119 - 128
  • [28] Cerebrospinal Fluid Total and Phosphorylated -Synuclein in Patients with Creutzfeldt-Jakob Disease and Synucleinopathy
    Schmitz, Matthias
    Villar-Pique, Anna
    Llorens, Franc
    Gmitterova, Karin
    Hermann, Peter
    Varges, Daniela
    Zafar, Saima
    Lingor, Paul
    Vanderstichele, Hugo
    Demeyer, Leentje
    Stoops, Erik
    Trojanowski, John Q.
    Lee, Virginia M-Y
    Zerr, Inga
    MOLECULAR NEUROBIOLOGY, 2019, 56 (05) : 3476 - 3483
  • [29] Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease
    Green, AJE
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2002, 28 (06) : 427 - 440
  • [30] The association of neuroleptic sensitivity in Lewy body disease with a false positive clinical diagnosis of Creutzfeldt-Jakob disease
    Lemstra, A. W.
    Schoemaker, N.
    Rozemuller-Kwakkel, A. J. M.
    van Gool, W. A.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (11) : 1031 - 1035